awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53787748-0F6620AA-ED69-44CC-8673-B19101DDDE4D
Q53787748-0F6620AA-ED69-44CC-8673-B19101DDDE4D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53787748-0F6620AA-ED69-44CC-8673-B19101DDDE4D
[Resistance to anti-angiogenic therapy: a clinical and scientific current issue].
P2860
Q53787748-0F6620AA-ED69-44CC-8673-B19101DDDE4D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53787748-0F6620AA-ED69-44CC-8673-B19101DDDE4D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f5f36540b0285858333eccef9c956474ca0dc966
P2860
Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials